Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 101 (4), 457-463
- https://doi.org/10.1016/s0091-6749(98)70353-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 273 Low doses of inhaled fluticasone propionate (FP) reduce bronchial hyperresponsiveness (BHR)Journal of Allergy and Clinical Immunology, 1996
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- BudesonideDrugs, 1992
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Bioequivalent doses of budesonide and prednisone in moderate and severe asthmaJournal of Allergy and Clinical Immunology, 1989
- Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthmaAllergy, 1989
- A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthmaJournal of Allergy and Clinical Immunology, 1977
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973